Experimental Ebola Vaccine Trial

Clinical trial NCT00072605 · COMPLETED

Trial details

NCT number: NCT00072605
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hemorrhagic Fever, Ebola Healthy

Start date: 2003-10-30
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.